Vice-versa, point-of-care devices as alternatives to conventional laboratory assays, may be inaccurate as point-of-care prothrombin time-ratio has poor agreement with laboratory prothrombin time-ratio in patients with acute traumatic coagulopathy, with 29% false-negative results [14]. The gene discussed is F2; the disease is blood coagulation disease.